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candidacy for endovascular aneurysm repair (EVAR)a
Variable No. (%) 30-day mortality, %Candidates for EVAR
EVAR 85 (54) 22.4
Open 71 (46) 49.2
Total 156
P .0007Not candidates for EVAR
EVAR 5 (9) 100
Open 49 (91) 46.9
Total 54
P .024a15 patients died before open repair.
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Objectives: In 2008, our division’s 5-year strategic
plan prioritized three programs. The top priority was,
“To become an internationally recognized center of excel-
lence for endovascular treatment of complex aortic pathol-
ogy extending from aortic valve to external iliac artery.”
Methods: We identiﬁed four key components to
achieve this strategic priority: (1) training at centers of
excellence (COE) in complex endovascular repair, (2) in-
dustry partnership to improve access to developing tech-
nologies, (3) prospective data collection, (4) development
and implementation of a physician-sponsored IDE for jux-
tarenal, pararenal, and thoracoabdominal aneurysms.
Results: After completing training at COEs and devel-
oping industry partnerships, our ﬁrst complex endovascular
aortic repair (deﬁnition: including 1 or more fenestration/
branch) was done in 2010. We have now performed 45 re-
pairs (15 commercially manufactured devices, 30 physician-
modiﬁed devices) for 3 common iliac, 20 juxtarenal, 8 par-
arenal, and 14 thoracoabdominal aneurysms. The repairs
incorporated 112 fenestrations/16 scallops; 94 (73%)
were bridged to a target vessel with a stent graft. All pa-
tients had complete 30-day follow-up for calculation of
30-day event rates: 2 (4.4%) mortality, 2 (4.4%) progres-
sion to dialysis, 8 (18%) access complications, 2 (4.4%)
type I or III endoleaks, and no instances of myocardial
infarction, bowel ischemia, paraplegia, paralysis, or stroke.
With this experience, we submitted a physician-sponsored
IDE to the Food and Drug Administration to evaluate
safety/efﬁcacy of physician-modiﬁed endografts for com-
plex aortic aneurysms in the fall of 2013 and obtained
approval on 30-day review.Conclusions: In 5 years, we developed a successful
complex endovascular aortic program that uses fenestrated
and branch repair techniques. Focused strategic planning
and a team approach to program development is an effec-
tive way for vascular surgery divisions to gain experience
and expertise with new complex technologies while
ensuring acceptable patient outcomes.
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Objectives: Current risk-prediction models for
abdominal aortic aneurysm (AAA) repair are suboptimal
and infrequently used. This study aimed to develop a reli-
able model for in-hospital mortality after AAA intervention
using data from the United Kingdom National Vascular
Database (UK NVD), applying rigorous and contemporary
statistical techniques to handle missing data.
Methods: UK NVD data for AAA interventions over a
15-month period (Feb 2010-Apr 2011) were analyzed. Mul-
tiple imputation methodology was applied to handle missing
data, and stepwise minimization of the Schwarz-Bayes crite-
rion was used to select optimal models of in-hospital mortal-
ity after AAA repair using (A) preoperative variables only or
(B) preoperative and perioperative variables. Two-thirds of
the data were used as the “modeling set,” with the remaining
third used as the “validation set.” Model performance was
assessed using receiver operating characteristic (ROC) curve
analysis, and compared with existing risk-prediction models.
Results: During the study period, 8088 AAA proce-
dures were recorded in the NVD, of which 5872 (72.6%)
were elective. Model A (9 variables) and B (10 variables)
showed excellent discrimination, with areas under the ROC
curve (AUC) of 0.89 and 0.92, respectively, for all AAA pro-
cedures. Separate models for endovascular/open or elective/
emergency interventions were not necessary, because a single
model (with type of repair and mode of admission as input
variables) performed better. Discrimination remained excel-
lent when considering only elective procedures (AUC 0.82
and 0.85) and was signiﬁcantly better than existing models
(model A, P < .001; model B, P ¼ .001).
Conclusions: The United Kingdom Aneurysm Risk
Model appears accurate and outperformed all existing tools
in this study. After further validation, the model could be
invaluable both for preoperative patient counseling and
accurate risk adjustment of published outcome data.
